Fiera Capital (Canada)
XLRN

Fiera Capital (Canada)’s Acceleron Pharma XLRN Stock Holding History

Fiera Capital (Canada)’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-431,009
Closed -$74.2M – 624
2021
Q3 		$74.2M Sell
431,009
-6,624
-2% -$866K 0.19% 67
2021
Q2 		$54.9M Sell
437,633
-11,750
-3% -$1.48M 0.14% 92
2021
Q1 		$60.9M Sell
449,383
-10,070
-2% -$1.3M 0.18% 73
2020
Q4 		$58.8M Buy
459,453
+3,416
+0.7% +$401K 0.16% 89
2020
Q3 		$51.3M Buy
456,037
+173,039
+61% +$17.2M 0.15% 86
2020
Q2 		$27M Buy
282,998
+256,156
+954% +$24.7M 0.09% 136
2020
Q1 		$2.41M Sell
26,842
-867
-3% -$67.4K 0.01% 293
2019
Q4 		$1.47M Sell
27,709
-703
-2% -$32.1K ﹤0.01% 418
2019
Q3 		$1.12M Sell
28,412
-3,869
-12% -$168K ﹤0.01% 418
2019
Q2 		$1.33M Sell
32,281
-1,589
-5% -$65.8K 0.01% 427
2019
Q1 		$1.58M Sell
33,870
-14,915
-31% -$655K 0.01% 429
2018
Q4 		$2.13M Buy
+48,785
New +$2.44M 0.01% 388

Fiera Capital (Canada)'s XLRN Position: Q4 2021 in Review

Fiera Capital (Canada) sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 431,009 shares — an estimated $74.2M sold.

Fiera Capital (Canada) first reported a position in XLRN in Q4 2018 and held it in 12 quarters. The position peaked at $74.2M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Fiera Capital (Canada) reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Fiera Capital (Canada) sold 431,009 Acceleron Pharma shares in Q4 2021, an estimated $74.2M.
  • Fiera Capital (Canada) first reported a position in Acceleron Pharma in Q4 2018 and held it in 12 quarters.
  • Fiera Capital (Canada)'s Acceleron Pharma position peaked at $74.2M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Fiera Capital (Canada)'s 13F filing for Q4 2021, filed 8 Feb 2022.